| Similar Articles |
|---|
 |
The Motley Fool
March 22, 2010
Dave Mock |
A Big Upgrade for CVS Caremark This bullish call comes from more than just one analyst.   |
The Motley Fool
August 31, 2011
Shubh Datta |
CVS Caremark Flattened by Higher Costs CVS Caremark profits remained relatively flat this quarter despite a substantial increase in revenue. |
The Motley Fool
May 4, 2011
Jason Knapp |
Generic Drugs and Old People Could Make You Rich CVS hasn't generated market-beating returns yet -- but it will. |
The Motley Fool
October 29, 2009
Brian Orelli |
Expressing Itself Nicely A nice quarter for Express Scripts. |
Financial Advisor
September 2012
Marla Brill |
Bargain Scavenger Steve Romick's contrarian style has helped FPA Crescent Fund outperform over the long term. |
The Motley Fool
October 2, 2011
Shubh Datta |
Would You Invest in This Drug Retailer? Is CVS Caremark worth your investment? |
The Motley Fool
November 3, 2010
Brian Orelli |
A Generic Prescription for Double-Digit Growth MedcoHealth Solutions has it. |
The Motley Fool
December 6, 2007
Selena Maranjian |
Your Drugs Are in the Mail Order medications online and save. According to a study by the Lewin Group, mail-order pharmacies, such as Medco and Express Scripts, can save you as much as 10% overall. |
The Motley Fool
November 4, 2009
Brian Orelli |
This One Is Thriving in a Recession Saving customers money makes it easy for Medco. |
The Motley Fool
February 23, 2006
Stephen D. Simpson |
Express Scripts Overdue for a Pause This pharmacy benefits manager is posting very good growth and has room for improvement, but what about the stock price? |
The Motley Fool
December 19, 2006
Matthew Crews |
Express Scripts' Takeover Battle The pharmacy benefits manager challenges CVS with a higher bid for rival Caremark RX. Investors, stay tuned -- this is far from over. |
The Motley Fool
July 27, 2004
Brian Gorman |
Medco's Pumped About Generics Generic drugs are actually helping improve Medco's margins, making it a winner with investors and health-care plans. |
The Motley Fool
April 29, 2010
Brian Orelli |
A Prescription to Investigate Further Let's not worry just yet about Medco's margins. |
The Motley Fool
January 17, 2012
Michael Olsen |
A Lesson in Feel-Good Investments Nice guys can finish last. Most managers aren't able to create value and grow their firms, at least not sustainably. |
The Motley Fool
August 1, 2007
Ryan Fuhrmann |
Foolish Forecast: CVS Caremark Gets Ready to Rumble CVS Caremark will announce its first combined quarterly results tomorrow. Competitors will be watching to see if the merger of drugstore chain and pharmacy benefit manager is a healthy one. |
The Motley Fool
June 30, 2011
David Williamson |
Pharmacy Benefits Delivering Drama CVS claims another Medco client and one messy split. |
The Motley Fool
September 3, 2010
Jordan DiPietro |
7 Big-Time Service Stocks Up for Grabs These large-cap stocks look pretty cheap. |
The Motley Fool
February 2, 2007
Ryan Fuhrmann |
Uncertain Outlook on CVS Has the retail pharmacy bit off more than it can chew? Investors may soon look back longingly to the day when CVS focused as much on organic, or internal, means to grow its business as it does on acquisitions to buy outside market share. |
The Motley Fool
January 8, 2007
Matthew Crews |
CVS' Tightrope Walk The drugstore chain's aggressive growth strategy continues to pay off -- for now. Investors, take note. |
The Motley Fool
August 6, 2008
Dan Dzombak |
3 Stocks Hitting High Notes These stocks are bucking the trend and hitting new highs. Take a look at: Wal-Mart... Marsh & McLennan... Genentech... |
Financial Planning
September 1, 2009
Ilana Polyak |
Evasive Action Steve Romick, manager of the FPA Crescent fund, is obsessed with protecting capital. |
The Motley Fool
July 23, 2008
Dan Dzombak |
3 Stocks Hitting High Notes These stocks are bucking the trend by reaching all-time highs. Take a look at: Norfolk Southern Corp... IBM... Autozone... |
The Motley Fool
November 2, 2006
Ryan Fuhrmann |
CVS Blazes a New Healthcare Trail Strong third-quarter earnings aside, the merger announcement with pharmacy benefit manager Caremark was the real shocker here. Investors, take note. |
BusinessWeek
July 29, 2010
Charles Stein |
Steve Romick: A "Free-Range" Fund Manager FPA Crescent's Romick puts his money wherever he sees value. |
